Creative Planning’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.5M | Buy |
117,236
+27,234
| +30% | +$5.02M | 0.01% | 412 |
|
|
2025
Q4 | $15.8M | Buy |
90,002
+21,419
| +31% | +$3.5M | 0.01% | 460 |
|
|
2025
Q3 | $9.61M | Buy |
68,583
+13,176
| +24% | +$1.78M | 0.01% | 580 |
|
|
2025
Q2 | $6.96M | Buy |
55,407
+28,835
| +109% | +$3.59M | 0.01% | 644 |
|
|
2025
Q1 | $3.64M | Buy |
26,572
+2,026
| +8% | +$290K | ﹤0.01% | 836 |
|
|
2024
Q4 | $3.75M | Buy |
24,546
+10,772
| +78% | +$1.82M | ﹤0.01% | 785 |
|
|
2024
Q3 | $2.67M | Sell |
13,774
-4,500
| -25% | -$941K | ﹤0.01% | 918 |
|
|
2024
Q2 | $4.24M | Buy |
18,274
+4,473
| +32% | +$972K | ﹤0.01% | 684 |
|
|
2024
Q1 | $2.98M | Buy |
13,801
+1,298
| +10% | +$304K | ﹤0.01% | 805 |
|
|
2023
Q4 | $3.24M | Sell |
12,503
-767
| -6% | -$188K | 0.01% | 711 |
|
|
2023
Q3 | $3.41M | Sell |
13,270
-1,604
| -11% | -$429K | ﹤0.01% | 647 |
|
|
2023
Q2 | $4.24M | Buy |
14,874
+1,261
| +9% | +$375K | 0.01% | 568 |
|
|
2023
Q1 | $3.78M | Buy |
13,613
+108
| +0.8% | +$29.9K | 0.01% | 575 |
|
|
2022
Q4 | $3.74M | Buy |
13,505
+1,893
| +16% | +$535K | 0.01% | 548 |
|
|
2022
Q3 | $3.1M | Buy |
11,612
+425
| +4% | +$90.3K | 0.01% | 555 |
|
|
2022
Q2 | $2.28M | Sell |
11,187
-1,504
| -12% | -$307K | ﹤0.01% | 675 |
|
|
2022
Q1 | $2.67M | Sell |
12,691
-297
| -2% | -$64.6K | ﹤0.01% | 633 |
|
|
2021
Q4 | $3.12M | Sell |
12,988
-661
| -5% | -$170K | 0.01% | 557 |
|
|
2021
Q3 | $3.86M | Buy |
13,649
+656
| +5% | +$215K | 0.01% | 487 |
|
|
2021
Q2 | $4.5M | Sell |
12,993
-12,580
| -49% | -$3.81M | 0.01% | 437 |
|
|
2021
Q1 | $7.15M | Sell |
25,573
-177
| -0.7% | -$47.7K | 0.01% | 333 |
|
|
2020
Q4 | $6.3M | Sell |
25,750
-583
| -2% | -$150K | 0.01% | 332 |
|
|
2020
Q3 | $7.47M | Buy |
26,333
+645
| +3% | +$180K | 0.02% | 260 |
|
|
2020
Q2 | $6.87M | Sell |
25,688
-582
| -2% | -$175K | 0.02% | 239 |
|
|
2020
Q1 | $8.31M | Buy |
26,270
+212
| +0.8% | +$64.3K | 0.03% | 185 |
|
|
2019
Q4 | $7.73M | Sell |
26,058
-85
| -0.3% | -$23.6K | 0.02% | 233 |
|
|
2019
Q3 | $6.09M | Sell |
26,143
-1,372
| -5% | -$319K | 0.02% | 252 |
|
|
2019
Q2 | $6.43M | Sell |
27,515
-1,368
| -5% | -$316K | 0.02% | 243 |
|
|
2019
Q1 | $6.83M | Buy |
28,883
+1,867
| +7% | +$588K | 0.02% | 218 |
|
|
2018
Q4 | $8.13M | Sell |
27,016
-1,596
| -6% | -$509K | 0.03% | 173 |
|
|
2018
Q3 | $10.1M | Buy |
28,612
+834
| +3% | +$287K | 0.04% | 164 |
|
|
2018
Q2 | $8.06M | Sell |
27,778
-155
| -0.6% | -$43.6K | 0.03% | 179 |
|
|
2018
Q1 | $7.65M | Sell |
27,933
-348
| -1% | -$108K | 0.03% | 180 |
|
|
2017
Q4 | $9.01M | Buy |
28,281
+2,013
| +8% | +$646K | 0.04% | 154 |
|
|
2017
Q3 | $8.22M | Sell |
26,268
-19,510
| -43% | -$5.78M | 0.04% | 159 |
|
|
2017
Q2 | $12.4M | Sell |
45,778
-2,713
| -6% | -$717K | 0.06% | 117 |
|
|
2017
Q1 | $13.3M | Buy |
48,491
+4,861
| +11% | +$1.37M | 0.07% | 105 |
|
|
2016
Q4 | $12.4M | Buy |
43,630
+6,640
| +18% | +$1.97M | 0.08% | 104 |
|
|
2016
Q3 | $11.6M | Sell |
36,990
-478
| -1% | -$142K | 0.07% | 110 |
|
|
2016
Q2 | $9.06M | Buy |
37,468
+5,545
| +17% | +$1.46M | 0.07% | 112 |
|
|
2016
Q1 | $8.31M | Buy |
31,923
+9,053
| +40% | +$2.39M | 0.06% | 112 |
|
|
2015
Q4 | $7.01M | Sell |
22,870
-72
| -0.3% | -$20.7K | 0.06% | 127 |
|
|
2015
Q3 | $6.7M | Buy |
+22,942
| New | +$7.58M | 0.06% | 130 |
|
|
2015
Q2 | – | Sell |
-6,316
| Closed | -$2.67M | – | 1298 |
|
|
2015
Q1 | $2.67M | Buy |
6,316
+1,762
| +39% | +$694K | 0.03% | 231 |
|
|
2014
Q4 | $1.55M | Buy |
4,554
+284
| +7% | +$91.9K | 0.02% | 334 |
|
|
2014
Q3 | $1.41M | Buy |
4,270
+491
| +13% | +$162K | 0.02% | 313 |
|
|
2014
Q2 | $1.19M | Buy |
3,779
+344
| +10% | +$104K | 0.02% | 340 |
|
|
2014
Q1 | $1.05M | Buy |
3,435
+908
| +36% | +$288K | 0.02% | 358 |
|
|
2013
Q4 | $706K | Sell |
2,527
-97
| -4% | -$25.1K | 0.01% | 409 |
|
|
2013
Q3 | $632K | Sell |
2,624
-461
| -15% | -$103K | 0.01% | 378 |
|
|
2013
Q2 | $664K | Buy |
+3,085
| New | +$659K | 0.02% | 331 |
|
Other funds holding BIIB
VCM
VPM
Creative Planning's BIIB Position: Q1 2026 in Review
Creative Planning increased its Biogen (BIIB) stake by 30% in Q1 2026, buying an estimated $5.02M and bringing the position to 117,236 shares worth $21.5M. The position accounts for 0.01% of the portfolio, ranked #412.
Creative Planning first reported a position in BIIB in Q2 2013 and has held it in 51 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.
- Creative Planning held 117,236 shares of Biogen worth $21.5M as of Q1 2026.
- Creative Planning bought 27,234 Biogen shares in Q1 2026, an estimated $5.02M.
- Biogen made up 0.01% of Creative Planning's portfolio in Q1 2026, its #412 holding.
- Creative Planning first reported a position in Biogen in Q2 2013 and has held it in 51 quarters since.
- 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.
Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.